Shu‐Hui Lin

1.7k total citations
87 papers, 1.3k citations indexed

About

Shu‐Hui Lin is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Shu‐Hui Lin has authored 87 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 20 papers in Oncology and 18 papers in Cancer Research. Recurrent topics in Shu‐Hui Lin's work include Cancer-related gene regulation (11 papers), RNA modifications and cancer (8 papers) and Lymphoma Diagnosis and Treatment (8 papers). Shu‐Hui Lin is often cited by papers focused on Cancer-related gene regulation (11 papers), RNA modifications and cancer (8 papers) and Lymphoma Diagnosis and Treatment (8 papers). Shu‐Hui Lin collaborates with scholars based in Taiwan, China and Vietnam. Shu‐Hui Lin's co-authors include Kun‐Tu Yeh, Shun‐Fa Yang, Mu‐Kuan Chen, Chiao‐Wen Lin, Ming‐Ju Hsieh, Yu‐Sheng Lo, Yi‐Ching Chuang, Shih‐Sung Chuang, Sheng‐Tsung Chang and Chih‐Jung Chen and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Shu‐Hui Lin

81 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shu‐Hui Lin Taiwan 22 548 363 238 197 155 87 1.3k
DA-TIAN BAU Taiwan 18 643 1.2× 305 0.8× 390 1.6× 142 0.7× 154 1.0× 144 1.4k
Raffaele Di Francia Italy 20 337 0.6× 363 1.0× 129 0.5× 198 1.0× 100 0.6× 66 1.1k
Guowei Chen China 23 670 1.2× 231 0.6× 329 1.4× 115 0.6× 139 0.9× 67 1.3k
Yi‐Chang Liu Taiwan 24 615 1.1× 285 0.8× 311 1.3× 144 0.7× 93 0.6× 123 2.0k
Shu Cao United States 23 478 0.9× 502 1.4× 237 1.0× 153 0.8× 321 2.1× 114 1.5k
Lijuan Hu China 23 793 1.4× 248 0.7× 316 1.3× 86 0.4× 131 0.8× 112 1.5k
Ignacio Romero Spain 23 476 0.9× 420 1.2× 218 0.9× 170 0.9× 279 1.8× 98 1.5k
Rahman Jamal Malaysia 23 653 1.2× 189 0.5× 393 1.7× 115 0.6× 92 0.6× 67 1.2k
Li Liang China 20 554 1.0× 389 1.1× 178 0.7× 82 0.4× 93 0.6× 67 1.3k
Suning Chen China 19 712 1.3× 333 0.9× 197 0.8× 99 0.5× 66 0.4× 231 1.7k

Countries citing papers authored by Shu‐Hui Lin

Since Specialization
Citations

This map shows the geographic impact of Shu‐Hui Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu‐Hui Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu‐Hui Lin more than expected).

Fields of papers citing papers by Shu‐Hui Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu‐Hui Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu‐Hui Lin. The network helps show where Shu‐Hui Lin may publish in the future.

Co-authorship network of co-authors of Shu‐Hui Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Shu‐Hui Lin. A scholar is included among the top collaborators of Shu‐Hui Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu‐Hui Lin. Shu‐Hui Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Jie, Qian Luo, Minjie Lu, et al.. (2025). METTL16 Promotes Lipid Metabolic Reprogramming and Colorectal Cancer Progression. International Journal of Biological Sciences. 21(11). 4782–4797.
2.
Lin, Shu‐Hui, et al.. (2024). Evaluation of the clinical significance of long non-coding RNA MALAT1 genetic variants in human lung adenocarcinoma. Aging. 16(6). 5740–5750. 2 indexed citations
3.
Ding, Jie, Juan Pu, Qian Luo, et al.. (2024). A novel lncRNA LOC101928222 promotes colorectal cancer angiogenesis by stabilizing HMGCS2 mRNA and increasing cholesterol synthesis. Journal of Experimental & Clinical Cancer Research. 43(1). 185–185. 16 indexed citations
4.
Cai, Ziming, et al.. (2024). Research Progress on Treating Spinal Cord Injury by Modulating the Phenotype of Microglia. Journal of Integrative Neuroscience. 23(9). 171–171. 4 indexed citations
5.
6.
7.
Hsieh, Ming‐Ju, Yu‐Sheng Lo, Hsin‐Yu Ho, et al.. (2023). FAM13A polymorphisms are associated with a specific susceptibility to clinical progression of oral cancer in alcohol drinkers. BMC Cancer. 23(1). 607–607. 6 indexed citations
8.
Velmurugan, Bharath Kumar, Chia‐Chieh Lin, Zuhair M. Mohammedsaleh, et al.. (2023). Prognostic and Clinical Implications of UNC13C expression in Hepatocellular Carcinoma Patients. International Journal of Medical Sciences. 20(9). 1235–1239. 1 indexed citations
9.
Yang, Qianqian, Yan Ding, Chaoying Zou, et al.. (2022). The deubiquitinating enzyme STAMBP is a newly discovered driver of triple-negative breast cancer progression that maintains RAI14 protein stability. Experimental & Molecular Medicine. 54(11). 2047–2059. 18 indexed citations
10.
Yeh, Kun‐Tu, Yu‐Ming Chuang, Yu‐Ting Lee, et al.. (2021). Methylomic analysis identifies C11orf87 as a novel epigenetic biomarker for GI cancers. PLoS ONE. 16(4). e0250499–e0250499. 4 indexed citations
11.
Lin, Ching‐Hsiung, Sheng‐Hao Lin, Kun‐Tu Yeh, et al.. (2020). Association between EGFR Gene Mutation and Antioxidant Gene Polymorphism of Non-Small-Cell Lung Cancer. Diagnostics. 10(9). 692–692. 7 indexed citations
12.
Velmurugan, Bharath Kumar, Shu‐Hui Lin, B. Mahalakshmi, et al.. (2020). Sodium Danshensu Inhibits Oral Cancer Cell Migration and Invasion by Modulating p38 Signaling Pathway. Frontiers in Endocrinology. 11. 568436–568436. 22 indexed citations
13.
Lin, Shu‐Hui, Hsin‐Kai Wang, Kun‐Tu Yeh, et al.. (2019). <p>c-MYC expression in T (III/IV) stage oral squamous cell carcinoma (OSCC) patients</p>. Cancer Management and Research. Volume 11. 5163–5169. 11 indexed citations
14.
Li, Ning, Yuanbin Song, Wei Zhao, et al.. (2016). Small interfering RNA targeting NF-κB attenuates lipopolysaccharide-induced acute lung injury in rats. BMC Physiology. 16(1). 7–7. 33 indexed citations
15.
Yang, Jia‐Sin, Chiao‐Wen Lin, Chun‐Yi Chuang, et al.. (2015). Carbonic anhydrase IX overexpression regulates the migration and progression in oral squamous cell carcinoma. Tumor Biology. 36(12). 9517–9524. 35 indexed citations
16.
Chang, Sheng‐Tsung, Yi‐Hsuan Lu, Chin‐Li Lu, et al.. (2013). Epstein–Barr virus is rarely associated with diffuse large B cell lymphoma in Taiwan and carries a trend for a shorter median survival time. Journal of Clinical Pathology. 67(4). 326–332. 25 indexed citations
17.
Wen, Chih-Chun, Yung‐Hsiang Chen, Wen-Ching Huang, et al.. (2013). Dietary Uptake of Wedelia chinensis Extract Attenuates Dextran Sulfate Sodium-Induced Colitis in Mice. PLoS ONE. 8(5). e64152–e64152. 28 indexed citations
18.
Colomo, Luís, Hongtao Ye, Hongxiang Liu, et al.. (2012). SOX11 is useful in differentiating cyclin D1‐positive diffuse large B‐cell lymphoma from mantle cell lymphoma. Histopathology. 61(4). 685–693. 35 indexed citations
19.
Chen, Tun‐Chieh, Wei‐Ru Lin, Po‐Liang Lu, et al.. (2011). Computer laboratory notification system via short message service to reduce health care delays in management of tuberculosis in Taiwan. American Journal of Infection Control. 39(5). 426–430. 8 indexed citations
20.
Chuang, Chao‐Hua, Pei‐Jen Chang, Wu‐Shiun Hsieh, et al.. (2007). The combined effect of employment status and transcultural marriage on breast feeding: a population‐based survey in Taiwan. Paediatric and Perinatal Epidemiology. 21(4). 319–329. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by DA-TIAN BAU Breakdown of academic impact, for papers by Raffaele Di Francia Breakdown of academic impact, for papers by Guowei Chen Breakdown of academic impact, for papers by Yi‐Chang Liu Breakdown of academic impact, for papers by Shu Cao Breakdown of academic impact, for papers by Lijuan Hu Breakdown of academic impact, for papers by Ignacio Romero Breakdown of academic impact, for papers by Rahman Jamal Breakdown of academic impact, for papers by Li Liang Breakdown of academic impact, for papers by Suning Chen
Rankless by CCL
2026